Epsilon Health has exited stealth mode, raising nearly $28M to launch an 'AI-native' radiology imaging group aimed at addressing the U.S. radiologist shortage.
Key Details
- 1Epsilon Health officially launched on Sept. 10, 2024, with almost $28 million in funding.
- 2The company aims to address the U.S. radiologist shortage by integrating proprietary AI directly into clinical workflows.
- 3Unlike most radiology AI startups, Epsilon positions itself as a radiology practice rather than a model vendor.
- 4The Series A financing was led by AlleyCorp, with participation from Uncork Capital, Renegade Partners, SemperVirens, and Alt Capital.
- 5Founder and CEO Rustin Rassoli has a background in mathematics, computer science, and experience with healthcare startups.
- 6Epsilon claims its AI can significantly speed up diagnostic interpretations while improving accuracy and consistency.
Why It Matters
Epsilon Health's approach could set a precedent by blending AI and clinical radiology teams at a practice level, not just as a software provider. If successful, this could help scale diagnostic capacity, reduce bottlenecks, and address the critical radiologist shortage.
Source
Radiology Business
Related News
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.
•Radiology Business
FDA Approves SimBioSys AI Tool for Breast Cancer Risk via MRI
SimBioSys received FDA clearance for TumorSight Risk, an AI tool assessing breast cancer recurrence risk using MRI.
•Radiology Business
FDA Clears MRI2CT AI for 3D Bone Visualization from MRI
MRI2CT's NextMR receives FDA clearance to generate 3D bone images from standard spine MRIs, reducing reliance on CT scans.